BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27384927)

  • 1. Development of enhancing agglutination reaction using gold nanoparticle for pre-transfusion testing.
    Choktaweesak N; Krasathong P; Ammaranond P
    Transfus Med; 2016 Oct; 26(5):360-364. PubMed ID: 27384927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced agglutination reaction of ABO subgroups by gold nanoparticle solution: implication for identification of ABO subgroups.
    Ammaranond P; Sriyarak J; Saejong S; Deesin P; Seereemaspun A; Rojanathanes R
    J Biomed Nanotechnol; 2011 Dec; 7(6):840-5. PubMed ID: 22416584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing the agglutination reaction in slide test for weak B blood group by gold nanoparticle solution: the first world report.
    Wiwanitkit V; Seereemaspun A; Rojanathanes R
    J Immunol Methods; 2007 Dec; 328(1-2):201-3. PubMed ID: 17936294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated point-of-care testing for ABO agglutination test: proof of concept and validation.
    El Kenz H; Corazza F
    Vox Sang; 2015 Jul; 109(1):79-85. PubMed ID: 25766458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-phase techniques in blood transfusion serology.
    Beck ML; Plapp FV; Sinor LT; Rachel JM
    Crit Rev Clin Lab Sci; 1986; 22(4):317-42. PubMed ID: 3081297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell antibody screening, red cell antibody identification and compatibility testing with the Column Agglutination Technology (CAT). The Bio Vue system.
    Lamy B; Tissot C; Heyd C; Lamy C
    Transfus Clin Biol; 1994; 1(2):121-7. PubMed ID: 8019646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study.
    Özen M; Yılmaz S; Özkan T; Özer Y; Pekel AA; Sunguroğlu A; Gürman G; Arslan Ö
    Turk J Haematol; 2018 Mar; 35(1):54-60. PubMed ID: 28533197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-stage papain-indirect antiglobulin test and LISS direct agglutination are not appropriate for pretransfusion screening for unexpected antibodies.
    Pereira A; Mazzara R; Gelabert A; Castillo R
    Haematologica; 1991; 76(6):475-8. PubMed ID: 1820984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ID and Bio Vue systems--comparison of two systems for the typing of erythrocyte antibodies].
    Eichler H; Klinge U; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1994; 32():149-52. PubMed ID: 9480072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of low ionic diluents for use with the Diamed antiglobulin gel test.
    Grey D; Connolly M; Erber WN
    Transfus Med; 2002 Feb; 12(1):63-9. PubMed ID: 11967139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of conventional tube test with diamed gel microcolumn assay for anti-D titration.
    Novaretti MC; Jens E; Pagliarini T; Bonifácio SL; Dorlhiac-Llacer PE; Chamone DA
    Clin Lab Haematol; 2003 Oct; 25(5):311-5. PubMed ID: 12974722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect antiglobulin test-crossmatch using low-ionic-strength saline-albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization.
    Dinardo CL; Bonifácio SL; Mendrone A
    Immunohematology; 2014; 30(1):1-5. PubMed ID: 25238242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for microplate techniques in liquid-phase blood grouping and antibody screening. A Joint Publication of the British Society for Haematology and the British Blood Transfusion Society. BCSH Blood Transfusion Task Force.
    Clin Lab Haematol; 1990; 12(4):437-60. PubMed ID: 2127909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-ionic-strength saline solution-antiglobulin test (LISS-AGT).
    Walker L
    Immunohematology; 2018 Jun; 34(2):57-60. PubMed ID: 29989420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pretransfusion bedside agglutination test is not a "Gold Standard"].
    Levy G
    Transfus Clin Biol; 2008 Nov; 15(5):318-21. PubMed ID: 18930684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New techniques for compatibility testing.
    Plapp FV
    Arch Pathol Lab Med; 1989 Mar; 113(3):262-9. PubMed ID: 2493236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three low-ionic-strength solutions for routine pretransfusion testing: antibody screening/identification, cross-matching, immune anti-ABO detection, and direct antiglobulin tests.
    Kaspi E; Mallié F; Gouvitsos J; Dettori I; Chiaroni J; Ferrera V
    Transfusion; 2009 Dec; 49(12):2772-3. PubMed ID: 20163691
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of weak D with a fully automated solid-phase red cell adherence system.
    Lai M; Mavilia G; d'Onofrio G; Leone G
    Transfusion; 2005 May; 45(5):689-93. PubMed ID: 15847655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward extended phenotype matching: a new operational paradigm for the transfusion service.
    Klapper E; Zhang Y; Figueroa P; Ness P; Stubbs J; Abumuhor I; Bailey J; Epperson L; Tauscher C; Enriquez E; Hashmi G; Seul M
    Transfusion; 2010 Mar; 50(3):536-46. PubMed ID: 19929860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mistyping of ABO grouping by polyagglutination].
    Kato T; Ishimaru K; Sekiguchi S
    Nihon Rinsho; 1997 Sep; 55(9):2378-84. PubMed ID: 9301304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.